Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
and mammalian target of rapamycin (mTOR
cell-permeable and selective spastin (a microtubule-severing AAA (ATPases associated with diverse cellular activities) protein) inhibitor with IC50 of 99 nM for Human spastin
Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011
CAS Number: 1401223-22-0
24 hours) reduces the expression of GPX4 protein
7-Chlorokynurenic acid sodium salt Size:Contact [email protected] for quotation and mammalian target of rapamycin7 Chlorokynurenic acid sodium salt (7 CKA sodium salt) is a potent and selective antagonist of the glycine B coagonist site of the N methyl D aspartate (NMDA) receptor (IC50=0. 56 M). 7 Chlorokynurenic acid sodium salt is also a potent inhibitor of the reuptake of glutamate into synaptic vesicles with a Ki of 0. 59 M. 7 Chlorokynurenic acid sodium salt has potent antinociceptive actions after neuraxial delivery. Product information CAS Number: 1263094